This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 14

Based on the information you provided, we found the following studies.

  • Ph 2 Double-Blind Randomized Study of Gemcitabine, Abraxane + Placebo vs Gemcitabine, Abraxane + 1 or 2 Truncated Courses of Demcizumab in Subjects with Metastatic Pancreatic Ductal Adenocarcinoma Study goal: compare the efficacy and safety of 1 or 2 truncated courses of new experimental drug, demcizumab, when given in combination with gemcitabine and Abraxane┬« to gemcitabine and Abraxane┬« (plus placebo).Administration of Gemcitabine and Abraxane┬« is standard treatment for pancreatic cancer. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of investigational drug INCB054329 (Study Drug) in Subjects With Advanced Malignancies (INCB 54329-101) Study purpose:determine dose that is safe and tolerable and select the doses that will be studied further;understand how INCB054329 enters and leaves the body over time;understand how INCB054329 acts on and in the body;observe any effects INCB054329 may have on the growth of certain types of cancers This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) Breast cancer CLL ( Chronic lymphocytic leukemia) Colon Cancer ( Malignant tumor of colon ) Lung cancer Pancreatic cancer Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I, open-label, dose escalation study of oral LGK974 in patients with malignancies dependent on Wnt ligands This research study is to find out if the study drug LGK974 is safe and has beneficial effects in people who have pancreatic adenocarcinoma, B-RAF mutant colorectal cancer, or tumors of other origin with specific genetic changes (also called mutations) upstream in the WNT signaling pathway. This study is researching all of the following topics: Colorectal / Colon / Rectal cancer Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • Improving Adherence to Oral Cancer Agents and Self-Care of Symptoms Using an IVR The purpose of the study is to: (1) determine if daily reminders will help patients take their anti-cancer pills as prescribed and; (2) test strategies to manage symptoms between doctor office visits. We are hoping to learn better ways to support patients who are prescribed oral anti-cancer pills. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Melanoma Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • Phase 2 Study of Gemcitabine, Cisplatin +/- Veliparib in Patients With Pancreas Adenocarcinoma with BRCA/ PALB2 Mutation and a Phase 2 Study of Veliparib in Previously Treated Pancreas Adenocarcinoma Part 1: To evaluate a combination of gemcitabine and cisplatin with or without veliparib in subjects pancreatic cancer. Veliparib is a new drug that belongs to a class of drugs called PARP inhibitors. Part 2: To evaluate veliparib in subjects with previously treated advanced pancreatic cancer. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A research study treating patients who have a diagnosis of pancreatic cancer, that has been staged as borderline operable, with chemotherapy and radiation therapy prior to surgery. To examine the order and results of treatments including chemotherapy and radiation therapy and surgery for pancreatic tumors that are staged as borderline operable. This study is researching all of the following topics: Colon Cancer ( Malignant tumor of colon ) Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A phase 3, multicenter, open-label, randomized study of nab-paclitaxel plus gemcitabine versus gemcitabine alone in subjects with surgically resected pancreatic adenocarcinoma. The purpose of this study is to determine whether the addition of the investigational drug nab-paclitaxel to gemcitabine will help to delay pancreatic cancer from coming back after surgery. Gemcitabine is a drug commonly used after pancreatic resection. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 14 studies
Show more studies